Literature DB >> 10618096

VP7 and VP4 genotyping of human group A rotavirus in Buenos Aires, Argentina.

M H Argüelles1, G A Villegas, A Castello, A Abrami, P D Ghiringhelli, L Semorile, G Glikmann.   

Abstract

Specific and sensitive tests for the detection and typing of group A rotavirus strains are needed for a more comprehensive knowledge of the epidemiology of rotaviral infection. In this study 500 stool specimens taken from 1996 to 1998 from children with acute diarrhea in Buenos Aires were examined. Group A rotavirus was unequivocally demonstrated in 62% of the samples tested by enzyme-linked immunosorbent assay (ELISA) for detection of VP6 antigen, polyacrylamide gel electrophoresis of double-stranded RNA, and reverse transcription-PCR (RT-PCR) for amplification of the VP7:G (1, 062 bp) and VP4:P (876 bp) genes. Only five positive specimens were found by RT-PCR but not by ELISA. G and P typing was carried out by nested amplification of variable sequences of the VP7 and the VP4 genes with six G- and five P-type-specific primers (multiplex PCR). Results obtained by this method showed the prevalence of the following G and P types: G1, 39%; G2, 43%; G4, 4%; P[8], 16%; P[4], 71%. Unexpectedly, the G-P type combination most frequently found was G2P[4] (43%) rather than G1P[8] (12%), which is the most commonly found worldwide. Unusual strains of the type G1P[4] accounted for 14% of the total, while mixed infections with more than one type were found in 10% of the samples. Detection of fecal rotavirus-specific immunoglobulin M (IgM) and IgA antibodies in consecutive samples of two patients taken at daily intervals demonstrated that high levels of IgM and IgA antibodies were detected on day 1 after the onset of disease and that the samples remained positive for about 10 days, after which virus shedding was no longer observed. Multiplex PCR offers a sensitive and specific alternative to determine the prevalence of group A rotavirus G and P types and to identify the emergence of uncommon strains, whereas detection of fecal IgM and IgA antibodies represents a useful supplement to virus detection for the diagnosis of current or recently acquired infections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618096      PMCID: PMC88704          DOI: 10.1128/JCM.38.1.252-259.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  56 in total

Review 1.  Recent advances in development of a rotavirus vaccine for prevention of severe diarrheal illness of infants and young children.

Authors:  A Z Kapikian; J Flores; T Vesikari; T Ruuska; H P Madore; K Y Green; M Gorziglia; Y Hoshino; R M Chanock; K Midthun
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

Review 2.  Human viral gastroenteritis.

Authors:  G Cukor; N R Blacklow
Journal:  Microbiol Rev       Date:  1984-06

3.  Comparison of direct and indirect enzyme immunoassays with direct ultracentrifugation before electron microscopy for detection of rotaviruses.

Authors:  G W Hammond; G S Ahluwalia; F G Barker; G Horsman; P R Hazelton
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

4.  Unusual diversity of human rotavirus G and P genotypes in India.

Authors:  M Ramachandran; B K Das; A Vij; R Kumar; S S Bhambal; N Kesari; H Rawat; L Bahl; S Thakur; P A Woods; R I Glass; M K Bhan; J R Gentsch
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

5.  Sequence analysis of the gene encoding the serotype-specific glycoprotein (VP7) of two new human rotavirus serotypes.

Authors:  K Y Green; Y Hoshino; N Ikegami
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

6.  Prevalence of human rotavirus serotypes in some European countries 1981-1988.

Authors:  G Gerna; A Sarasini; S Arista; A di Matteo; L Giovannelli; M Parea; P Halonen
Journal:  Scand J Infect Dis       Date:  1990

7.  Infection and cross-protection studies of winter dysentery and calf diarrhea bovine coronavirus strains in colostrum-deprived and gnotobiotic calves.

Authors:  Z R El-Kanawati; H Tsunemitsu; D R Smith; L J Saif
Journal:  Am J Vet Res       Date:  1996-01       Impact factor: 1.156

8.  Monoclonal antibodies for the direct detection of influenza-A virus by ELISA in clinical specimens from patients with respiratory infections.

Authors:  G Glikmann; C H Mordhorst; C Koch
Journal:  Clin Diagn Virol       Date:  1995-05

9.  Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.

Authors:  J W Burns; M Siadat-Pajouh; A A Krishnaney; H B Greenberg
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

10.  Classification of rotavirus into G and P types with specimens from children with acute diarrhea in New Delhi, India.

Authors:  M Husain; P Seth; L Dar; S Broor
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

View more
  11 in total

1.  Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999.

Authors:  M Iturriza-Gómara; B Isherwood; U Desselberger; J Gray
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Emergence of G9 P[6] human rotaviruses in Argentina: phylogenetic relationships among G9 strains.

Authors:  K Bok; G Palacios; K Sijvarger; D Matson; J Gomez
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

3.  Group A rotavirus in sewage samples from Barcelona and Cairo: emergence of unusual genotypes.

Authors:  Cristina Villena; Waled Morsy El-Senousy; F Xavier Abad; Rosa M Pintó; Albert Bosch
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

4.  Molecular epidemiology of group A rotavirus diarrhea among children in Buenos Aires, Argentina, from 1999 to 2003 and emergence of the infrequent genotype G12.

Authors:  A A Castello; M H Argüelles; R P Rota; A Olthoff; B Jiang; R I Glass; J R Gentsch; G Glikmann
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

5.  HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice.

Authors:  Andrea S Laimbacher; Laura E Esteban; Alejandro A Castello; Juan C Abdusetir Cerfoglio; Marcelo H Argüelles; Graciela Glikmann; Alejandra D'Antuono; Nora Mattion; Mabel Berois; Juan Arbiza; Monika Hilbe; Elisabeth M Schraner; Michael Seyffert; Christiane Dresch; Alberto L Epstein; Mathias Ackermann; Cornel Fraefel
Journal:  Mol Ther       Date:  2012-06-19       Impact factor: 11.454

6.  Diversity of group A human rotavirus types circulating over a 4-year period in Madrid, Spain.

Authors:  Alicia Sánchez-Fauquier; Isabel Wilhelmi; Javier Colomina; Eusebio Cubero; Enriqueta Roman
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  Development of a human rotavirus induced diarrhea model in Chinese mini-pigs.

Authors:  Jin-Tao Li; Jing Wei; Hong-Xia Guo; Jiang-Bo Han; Nan Ye; Hai-Yang He; Tian-Tian Yu; Yu-Zhang Wu
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

8.  Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India.

Authors:  Indrani Banerjee; Sasirekha Ramani; Beryl Primrose; Prabhakar Moses; Miren Iturriza-Gomara; James J Gray; Shabbar Jaffar; Bindhu Monica; Jaya Prakash Muliyil; David W Brown; Mary K Estes; Gagandeep Kang
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

9.  Molecular Characterization of Human Rotavirus from Children with Diarrhoeal Disease in Sokoto State, Nigeria.

Authors:  B R Alkali; A I Daneji; A A Magaji; L S Bilbis; F Bande
Journal:  Mol Biol Int       Date:  2016-03-09

10.  Prevalence of enteropathogenic viruses and molecular characterization of group A rotavirus among children with diarrhea in Dar es Salaam Tanzania.

Authors:  Sabrina J Moyo; Njolstad Gro; Vainio Kirsti; Mecky I Matee; Jesse Kitundu; Samwel Y Maselle; Nina Langeland; Helge Myrmel
Journal:  BMC Public Health       Date:  2007-12-27       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.